Bethanie Mattek-Sands
Bethanie Mattek-Sands (née Bethanie Lynn Mattek; born March 23, 1985) is an American professional tennis player. She has won nine Grand Slam titles (five in women's doubles and four in mixed doubles), and an Olympic gold medal, and is a former world No. 1 in doubles.
Mattek-Sands at the 2019 Wimbledon Championships | ||||||||||||
| Country (sports) | United States | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Residence | Phoenix, Arizona, U.S. | |||||||||||
| Born | March 23, 1985 Rochester, Minnesota, U.S. | |||||||||||
| Height | 5 ft 6 in (1.68 m) | |||||||||||
| Turned pro | 1999 | |||||||||||
| Plays | Right (two-handed backhand) | |||||||||||
| Coach | Jared Jacobs | |||||||||||
| Prize money | US$8,376,770 | |||||||||||
| Official website | bmattek.com | |||||||||||
| Singles | ||||||||||||
| Career record | 376–322 (53.9%) | |||||||||||
| Career titles | 0 | |||||||||||
| Highest ranking | No. 30 (July 11, 2011) | |||||||||||
| Current ranking | No. 1356 (12 February 2024) | |||||||||||
| Grand Slam singles results | ||||||||||||
| Australian Open | 3R (2015) | |||||||||||
| French Open | 4R (2013) | |||||||||||
| Wimbledon | 4R (2008) | |||||||||||
| US Open | 3R (2015) | |||||||||||
| Doubles | ||||||||||||
| Career record | 446–246 (64.5%) | |||||||||||
| Career titles | 30 | |||||||||||
| Highest ranking | No. 1 (January 9, 2017) | |||||||||||
| Current ranking | No. 36 (12 February 2024) | |||||||||||
| Grand Slam doubles results | ||||||||||||
| Australian Open | W (2015, 2017) | |||||||||||
| French Open | W (2015, 2017) | |||||||||||
| Wimbledon | SF (2010) | |||||||||||
| US Open | W (2016) | |||||||||||
| Other doubles tournaments | ||||||||||||
| Tour Finals | F (2016) | |||||||||||
| Olympic Games | QF (2021) | |||||||||||
| Mixed doubles | ||||||||||||
| Career titles | 4 | |||||||||||
| Grand Slam mixed doubles results | ||||||||||||
| Australian Open | W (2012) | |||||||||||
| French Open | W (2015) | |||||||||||
| Wimbledon | SF (2015) | |||||||||||
| US Open | W (2018, 2019) | |||||||||||
| Other mixed doubles tournaments | ||||||||||||
| Olympic Games | W (2016) | |||||||||||
| Team competitions | ||||||||||||
| Fed Cup | F (2010, 2017, 2018) record 10–7 | |||||||||||
| Hopman Cup | W (2011) | |||||||||||
Olympic Games
| ||||||||||||
| Last updated on: 12 February 2024. | ||||||||||||
In women's doubles, Mattek-Sands has won 30 career titles, including five Grand Slam titles at the 2015 Australian Open, 2015 French Open, 2016 US Open, 2017 Australian Open and 2017 French Open, all partnering Lucie Šafářová. The pair also were the runners-up of the 2016 WTA Finals. Mattek-Sands became the world No. 1 in doubles on January 9, 2017, and held the top ranking for 32 consecutive weeks.
Mattek-Sands has also found great success in mixed doubles; she won the 2012 Australian Open with and the 2015 French Open and a gold medal at the 2016 Rio Olympics. Mattek-Sands then suffered a major knee injury in 2017 that required surgery and a year away from competition to heal, but eventually came back to win the 2018 and 2019 US Open mixed doubles titles, both partnering Jamie Murray. Mattek also played World TeamTennis for the Hartford FoxForce in 2000, the Sacramento Capitals in 2006, and the New York Sportimes in 2008.
Mattek-Sands has also won five singles and three doubles titles on the ITF Women's Circuit. Her best results in singles on the WTA Tour are reaching the fourth round of two major events (Wimbledon in 2008 and the French Open in 2013), the semifinals of the tournaments in Cincinnati in 2005 and Birmingham in 2008, and the final of the Bell Challenge in 2008 and 2010. She reached a career-high singles ranking of No. 30 in the world on July 11, 2011.
In 2016, hacked documents from the World Anti-Doping Agency (WADA) revealed that Mattek-Sands had twice applied for a therapeutic-use exemption for hydrocortisone and DHEA. Both times the request was granted by the International Tennis Federation before being revoked by WADA, but an application for exemption for hydrocortisone alone was eventually approved. Mattek-Sands has refused to comment on the exemption.